Stay updated on Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.6%
    Check dated 2025-05-01T23:53:43.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-04-24T15:35:08.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial related to mitochondrial diseases and epilepsy, while adding new identifiers and conditions related to the study.
    Difference
    26%
    Check dated 2025-04-17T11:03:55.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.6%
    Check dated 2025-04-10T05:54:22.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page has added information about Leigh Syndrome while removing references to Status Epilepticus.
    Difference
    0.7%
    Check dated 2025-04-03T00:21:10.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-26T12:52:15.000Z thumbnail image

Stay in the know with updates to Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.